Table 1 Baseline patient demographic and clinical characteristics
Characteristic | Pooled data (2004–2012) N = 11,557 n (%) | Overlapping time period (2007–2009) | |
|---|---|---|---|
COREa | EU-COREa | ||
NÂ =Â 2827 n (%) | NÂ =Â 3333 n (%) | ||
Male | 6587 (57.0) | 1454 (51.4) | 2150 (64.5) |
Ageb (years), median (range) | 62.0 (1–103) | 56.5 (4–99) | 63.0 (1–103) |
 <65 years | 7111 (61.5) | 1945 (68.8) | 1758 (52.7) |
 ≥65 years | 4441 (38.4) | 882 (31.2) | 1572 (47.2) |
 ≥75 years | 1732 (15.0) | 265 (9.4) | 734 (22.0) |
Body weight (kg), median (range) | 78.0 (6–275) | 81.9 (15–259) | 75.0 (6–200) |
Race, Caucasian | 7191 (62.2) | 1967 (69.6) | 3058 (91.7) |
Setting prior to daptomycin therapyc | |||
 Hospital | 7278 (63.0) | 1359 (49.3) | 2558 (76.7) |
 Nursing home/extended care | 431 (3.7) | 152 (5.4) | 102 (3.1) |
 Community | 3772 (32.6) | 1275 (45.1) | 637 (19.1) |
 Other | 57 (0.5) | 5 (0.2) | 24 (0.7) |